e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Disease control and quality of life in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Justification for statistical process control in daily home spirometry for COPD patients
W. Sirichana, M. H. Patel, M. S. Taylor, C. H. Tseng, I. Barjaktarevic, E. C. Kleerup, C. B. Cooper (Los Angeles, Philadelphia, United States Of America; Bangkok, Thailand)
Source:
Annual Congress 2013 –Disease control and quality of life in airway diseases
Session:
Disease control and quality of life in airway diseases
Session type:
Thematic Poster Session
Number:
820
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Sirichana, M. H. Patel, M. S. Taylor, C. H. Tseng, I. Barjaktarevic, E. C. Kleerup, C. B. Cooper (Los Angeles, Philadelphia, United States Of America; Bangkok, Thailand). Justification for statistical process control in daily home spirometry for COPD patients. Eur Respir J 2013; 42: Suppl. 57, 820
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Comparison of modified medical research council scale and COPD assessment test in subjects with COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Romanian experience in running COPD awareness campaigns
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016
Assessment of the COPD patients’ care: An audit of clinical practice
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
The impact of comorbidities on pulmonary rehabilitation outcomes in patients with COPD
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Quality of home spirometry data in asthmatic patients
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Telehealthcare in COPD – A feasibility trial
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Is it feasible for respiratory physiologists to carry out inhaler device technique checks during routine pulmonary function tests?
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
Home telerehabilitation maintenance program for patients affected by COPD and CHF
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016
Minimal pulmonary rehabilitation program in subjects with COPD
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Coping with COPD in patients home
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic
Source: International Congress 2014 – COPD exacerbations
Year: 2014
The predictors for COPD exacerbations using remote patient monitoring
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Patient specific parameter thresholding to support domiciliary monitoring in COPD
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Do pedometers maintain the benefits of pulmonary rehabilitation in COPD patients?
Source: International Congress 2016 – Best abstracts in physical activity and telemedicine
Year: 2016
Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Effectiveness of temporary positive expiratory pressure (T-PEP) at home and at hospital in patients with severe COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Minimal versus specialist equipment for the delivery of pulmonary rehabilitation in COPD
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept